{
	"slug": "cystitis-pyelonephritis-women",
	"title": "Cystitis and Pyelonephritis in Women",
	"authors": [
		"Michelle Lin, MD"
	],
	"created": "2011/09/02",
	"updates": null,
	"categories": [
		"Infectious Disease",
		"Genitourinary"
	],
	"body": "\n\n\n_2010 Infectious Disease Society of America (IDSA) and European Society for Microbiology and Infectious Diseases (ESMID) guidelines_\n\n**Target population**\n\n- Acute, uncomplicated cystitis and pyelonephritis in women \n- Premenopausal, non-pregnant women without known urological abnormalities or co-morbidities (i.e. DM)\n\n## Acute uncomplicated cystitis\n\n1. <span class=\"drug\">Nitrofurantoin</span> (100 mg PO BID x 5 days)\n2. **<span class=\"drug\">Trimethoprim</span>-sulfamethoxazole** (1 DS tab PO BID x 3 days)\n   - Rising resistance rates\n   - Only give if local antibiogram shows &lt;20% resistance\n3. <span class=\"drug\">Fosfomycin</span>(3 gm PO x 1)â€¨\n   - Slightly less efficiacy compared to standard short-course regimens \n4. <span class=\"drug\">Pivmecillinam</span> (400 mg PO BID x 3-7 days) \n   - Only available in Europe\n5. **Fluoroquinolones** (3-day course of <span class=\"drug\">ofloxacin</span>, <span class=\"drug\">ciprofloxacin</span>, or <span class=\"drug\">levofloxacin</span>) \n   - Avoid if possible to minimize selection of drug-resistant organisms\n\n**Beta-lactams** (3-7 day course of <span class=\"drug\">amoxicillin-clavulanate</span>, <span class=\"drug\">cefdinir</span>, <span class=\"drug\">cefaclor</span>, <span class=\"drug\">cefpodoxime-proxetil)</span>\n\n- Avoid if possible to minimize selection of drug-resistant organisms\n- Inferior efficacy compared with standard regimens\n- <span class=\"drug\">Cephalexin</span> less well studied\n\n## Acute Pyelonephritis\n\nUrine analysis and urine culture should always be performed \n\n<span class=\"drug\">Ciprofloxacin</span> (500 mg po BID x 7 days) +/- <span class=\"drug\">ciprofloxacin</span> 400 mg IV x 1 dose\nIf **>10% resistance to fluoroquinolones**, give 1-time IV dose:\n\n- <span class=\"drug\">Ceftriaxone</span> 1 gm IV, or \n- An aminoglycoside \n\nIf **&lt;10% resistance rate,** alternative oral fluoroquinolone outpatient dosing options:\n\n- <span class=\"drug\">Ciprofloxacin</span> XR 1000 mg po daily x 7 days, or\n- <span class=\"drug\">Levofloxacin</span> 750 mg po daily x 5 days \n\n<span class=\"drug\">Trimethoprim-sulfamethoxazole</span> (1 tab DS PO BID x 14 days)\n1\\.  If resistance rate unknown, give 1-time dose of <span class=\"drug\">ceftriaxone</span> 1 gm IV or aminoglycoside first\n\n**Beta-lactams** (10-14 day course)\n1\\.  Because of less efficacy, give 1-time dose of <span class=\"drug\">ceftriaxone</span> 1 gm IV or aminoglycoside first \n\n## References\n\n- Gupta K et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the IDSA and the ESMID. Clin Infect Dis. 2011; 52(5). [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/10589881)]\n"
}